(Q45347103)

13 December 2017

title

Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome? (English)

1 reference

13 December 2017

1 reference

Laëtitia Delbe-Bertin

1

1 reference

13 December 2017

Bilal Aoun

2

1 reference

13 December 2017

Elena Tudorache

3

1 reference

13 December 2017

Hélène Lapillone

4

1 reference

13 December 2017

Tim Ulinski

5

1 reference

13 December 2017

publication date

5 December 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

28

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

447-451

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-012-2361-z

13 December 2017

exact match

0 references

cites work

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2361-Z

Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2361-Z

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2361-Z

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2361-Z

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2361-Z

Does rituximab aggravate pre-existing hypogammaglobulinaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2361-Z

Rituximab efficiency in children with steroid-dependent nephrotic syndrome

21 January 2018

1 reference

12 December 2020

Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?

1 reference

12 December 2020

Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?

1 reference

12 December 2020

Rituximab therapy for steroid-dependent minimal change nephrotic syndrome

1 reference

12 December 2020

Hypogammaglobulinemia in pediatric liver transplant recipients

1 reference

12 December 2020

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

1 reference

12 December 2020

Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.

1 reference

12 December 2020

Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations

1 reference

12 December 2020

Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery

1 reference

12 December 2020

10.1007/S00467-012-2361-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1017924951

0 references

1 reference